AI brief of an SEC Form 8-K · Western Alliance Bancorporation (WAL)

Western Alliance to take $126.4 million charge on defaulted LAM trade finance loan

Mixed Impact 4 of 5 earnings Written later

Western Alliance said counterparties tied to Jefferies will not repay the remaining $126.4 million loan balance and will stop payments, so the bank will record a non-cash impairment charge of the same amount in the first quarter of 2026. Management says planned securities gains and expense cuts should offset $100 million of the charge, leaving a $26 million gap, and it still expects another profitable quarter.

Key points

  • Counterparties will not make a $42.125 million principal payment and will discontinue future payments; the outstanding balance is $126.4 million.
  • The bank filed a complaint in New York Supreme Court on March 6, 2026, alleging breach of contract and fraud.
  • Management targets $100 million of offsets: $50 million of securities gains (about $45 million realized quarter-to-date) and $50 million of expense savings.
  • The after-tax impact would reduce the year-end 2025 CET1 ratio by only 7 basis points, according to the company.

The filing

CompanyWestern Alliance Bancorporation (WAL)
Form8-K, current report
Filed with the SECMar 6, 2026, 7:30 AM ET
Accession number0001628280-26-015454

Items reported: 2.06 Material Impairment7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:17 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 06, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.